ALZN Earnings

Quarterly EPS
$-11.42
Q1 2025
$-3.60
Q2 2025
$-1.75
Q3 2025
$0.00
Q4 2025
$-1.28
Q1 2026
$-0.30
Q2 2026
$-0.58
Q3 2026
$-0.71
Q4 2026
Latest RevenueN/A
Latest Net Income-2869949
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q4 2026-$0.710-2869949
Q3 2026-$0.580-2198991+66.9%
Q2 2026-$0.300-1000758+91.7%
Q1 2026-$1.280-2702684+88.8%
Q4 20250-1139445
Q3 2025-$1.750-1039434+94.8%
Q2 2025-$3.600-1361563+91.0%
Q1 2025-$11.420-974411+78.9%
Q4 20240-851529
Q3 2024-$33.930-2662418
Q2 2024-$39.870-2906033
Q1 2024-$54.00-3527766
Alzamend Neuro (ALZN) — Earnings